Oil Spike Spooks Sensex
The Sensex slid 388.19 points (0.49%) to 78,154.25 and the Nifty 50 shed 112.10 points (0.46%) to close at 24,471.70, slipping below the psychologically important 24,500 mark. The proximate trigger was a sharp rise in crude oil, now at $89.65 a barrel (+0.83%), amid reported Middle East tensions and Strait-related supply fears. Since India imports over 80% of its crude needs, elevated oil prices simultaneously pressure the current account, the rupee, and inflation expectations, a combination that markets are clearly pricing in today.
Rupee Under Renewed Pressure
The rupee fell 13 paise to settle at 95.43 against the dollar, tracking the crude spike, though it is quoted flat at 95.42 in early trade. A weaker rupee raises import costs for oil marketing companies and could complicate the inflation trajectory the RBI has been managing. Analysts note the currency has held relatively stable versus regional peers, which some see as a mitigating factor amid the broader risk-off mood.
FIIs Return, DIIs Follow
Foreign institutional investors bought a net ₹259 crore of Indian equities on Tuesday, marking a third straight session of buying, while domestic institutions turned net buyers after selling ₹1,290 crore the previous session. This dual support cushioned the index fall despite the oil-driven selloff, and broader markets showed resilience with the Smallcap 100 index actually gaining 0.22% even as the headline indices fell. Strong Q1 earnings and a comparatively stable rupee appear to be underpinning institutional confidence even as headline indices wobble.
Earnings Season: A Mixed Bag
Tuesday's results were sharply divergent: Manappuram Finance's profit quadrupled to ₹585 crore with AUM up 57% to ₹69,635 crore, RVNL posted an 18-19% profit rise with operating profit more than tripling, and NBCC's profit rose 17% despite a revenue decline as margins improved. On the other side, Zydus Lifesciences saw profit fall 36% to ₹939.8 crore despite 22% revenue growth, and MRF faced margin pressure, underscoring that topline growth alone is not translating uniformly into profitability this quarter.
Gland Pharma Rally Meets Brokerage Divide
Gland Pharma shares jumped 12% to a 52-week high after Q1FY27 profit rose 47% YoY on strong CDMO growth, but brokerage views are starkly split: Jefferies upgraded to 'buy' with a ₹3,350 target while Goldman Sachs maintains a 'sell' with a ₹2,125 target, and Elara downgraded to 'Accumulate' after the stock's 40% three-month rally. This divergence is a useful reminder that post-rally price targets can diverge sharply even on the same set of published results.
IPO Pipeline Stays Busy
Shiprocket raised ₹727.41 crore from anchor investors including Goldman Sachs, HDFC MF and SBI MF ahead of its ₹1,617.48 crore IPO priced at ₹92-97, with grey market premium suggesting a possible listing pop. Lalithaa Jewellery Mart's ₹1,700 crore issue opens August 17 at ₹190-201, valuing the company near ₹11,250 crore, while LEAP India was subscribed 8.38 times and Technocraft Ventures saw 38.69 times demand. Separately, 34 companies are reportedly racing to launch IPOs worth ₹45,000 crore before September 30 to beat regulatory deadlines, signalling a busy primary market pipeline into year-end.
Index Reshuffle: BSE In, Wipro Out
NSE Indices will implement changes effective September 30, with BSE entering the Nifty 50 in place of Wipro, which moves to the Nifty Next 50, while Hitachi Energy and Polycab join the Nifty 100. Nuvama estimates this could draw roughly $695 million of passive inflows into BSE against $240 million of outflows from Wipro. BSE shares are up 37% year-to-date despite a 6% pullback over the past month, illustrating how index-inclusion flows can move prices independent of near-term fundamentals.
Global Backdrop and Policy Signals
US markets closed lower overnight — the Dow at 53,791.85 (-0.34%), S&P 500 at 7,728.2 (-0.32%) and Nasdaq at 26,445.45 (-0.60%) — even as J.P. Morgan raised its S&P 500 year-end target to 8,000 citing AI and earnings optimism. Fitch affirmed India's sovereign rating at 'BBB-' with a stable outlook, a steady but unspectacular signal on the fiscal front, while SBI is tapping the dollar bond market for at least $500 million in five-year notes, a reminder that Indian issuers continue to access offshore funding despite rising global borrowing costs.